STAT Plus: Lawmakers urge Trump administration to alter trade deal or Americans will pay more for drugs
More than 100 Democratic members of Congress urged the Trump administration to remove pending language from the U.S.-Mexico-Canada Agreement trade agreement that would lock the U.S into at least 10 years of marketing exclusivity for biologics, a move they argue will hurt taxpayers and patients.
In a letter sent on Thursday to U.S. Trade Representative Robert Lighthizer, the lawmakers cited a provision of the deal, which has not yet been ratified, that would prevent a company seeking to sell a lower-cost version of a brand-name biologic from doing so for a decade. For this reason, they maintain the trade pact as it currently stands runs counter to efforts by President Trump to lower drug prices.
Continue to STAT Plus to read the full story…
